|
commercialization
|
NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM
75N98026R00109 · NATIONAL INSTITUTES OF HEALTH · NIH NCI
|
biomedical clinical
cybersecurity
ai data science
|
— |
2026-07-10 |
2026-09-21 |
15 |
|
commercialization
|
NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM
75N98026R00109 · NATIONAL INSTITUTES OF HEALTH · NIH NCI
|
biomedical clinical
public health
computing communications
|
— |
2026-07-10 |
2026-09-21 |
15 |
|
commercialization
|
NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM
75N98026R00109 · NATIONAL INSTITUTES OF HEALTH · NIH NCI
|
biomedical clinical
public health
ai data science
|
— |
2026-07-24 |
2026-09-21 |
15 |
|
commercialization
|
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
75A50126R00001_RFP_NPIVS_27 · OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE · BARDA - ASPR / DAAPPO / BARDA DCMA
|
public health
biomedical clinical
emergency disaster resilience
|
— |
2026-08-17 |
2026-10-30 |
54 |
|
commercialization
|
TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform
S-191192 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR
|
biomedical clinical
public health
biomedical clinical
|
— |
2026-06-15 |
2026-12-15 |
100 |
|
commercialization
|
TECHNOLOGY LICENSING OPPORTUNITY: DC Recruiter
S-195061 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR
|
biomedical clinical
public health
national security defense
|
— |
2026-06-15 |
2026-12-15 |
100 |
|
commercialization
|
TECHNOLOGY LICENSING OPPORTUNITY: DC Recruiter
S-195061 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR
|
biomedical clinical
public health
national security defense
|
— |
2026-06-15 |
2026-12-15 |
100 |
|
commercialization
|
TECHNOLOGY LICENSING OPPORTUNITY: NanoFET
S-194657 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR
|
biomedical clinical
public health
national security defense
|
— |
2026-06-17 |
2026-12-17 |
102 |
|
commercialization
|
TECHNOLOGY LICENSING OPPORTUNITY: NanoFET
S-194657 · ENERGY, DEPARTMENT OF · TRIAD - DOE CONTRACTOR
|
biomedical clinical
public health
national security defense
|
— |
2026-06-17 |
2026-12-17 |
102 |
|
commercialization
|
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
PA-27-102 · National Institutes of Health
|
biomedical clinical
materials manufacturing
ai data science
|
— |
2026-05-28 |
2027-04-05 |
211 |
|
commercialization
|
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
PA-27-100 · National Institutes of Health
|
biomedical clinical
public health
materials manufacturing
|
— |
2026-05-28 |
2027-04-05 |
211 |
|
commercialization
|
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
PAR-27-098 · National Institutes of Health
|
biomedical clinical
public health
materials manufacturing
|
— |
2026-05-28 |
2029-04-05 |
942 |
|
commercialization
|
Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics
W911SR-26-R-HEAL · DEPT OF THE ARMY · W6QK ACC-APG
|
biomedical clinical
national security defense
public health
|
— |
2026-05-06 |
— |
— |
|
commercialization
|
Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics
W911SR-26-R-HEAL · DEPT OF THE ARMY · W6QK ACC-APG
|
national security defense
biomedical clinical
public health
|
— |
2026-04-23 |
— |
— |
|
commercialization
|
Participant Basic Agreement (PBA) Opportunity - Threat Agnostic Host-Directed Therapeutics
· DEPT OF DEFENSE
|
national security defense
biomedical clinical
public health
|
— |
2026-04-23 |
— |
— |